Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 442, 734 (17 August 2006) | doi:10.1038/442734a; Published online 16 August 2006
More fizz at Pfizer?
Top of page
Abstract
Young blood is taking the helm at the world's biggest drug firm. Colin Macilwain assesses whether this is likely to revive its share price.
As chief executive, Hank McKinnell cut an avuncular figure in his company's television commercials, reassuring viewers that when their doctors needed medicine, Pfizer would be there.
To read this story in full you will need to login or make a payment (see right).